Daniel Long's most recent trade in Septerna Inc. was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Septerna Inc | Daniel Long | SVP, Drug Discovery | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Septerna Inc | Daniel Long | SVP, Drug Discovery | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 10 Nov 2025 | 3,501 | 92,911 | - | 18.1 | 63,223 | Common Stock |
| Septerna Inc | Daniel Long | SVP, Drug Discovery | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |